from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2743c/-

LFCtreatmentdescriptionclass of inhibitor

-0.174

Amikacinug/mL Amikacintranslation

-1.116

Cap5-10ug/mL Capreomycintranslation

-0.044

Rox10-50 ug/mL Roxithromycintranslation

1.214

SM2-5 ug/mL Streptomycintranslation

-0.744

Tet5-10 ug/mL Tetracyclinetranslation

-0.669

Rif0.2-5ug/mL Rifampicintranscription

-0.253

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.385

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.188

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.087

CPZ10-50 ug/mL Chlorpromazinerespiration

0.753

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.238

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.860

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.528

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.250

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.123

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.305

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.481

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.388

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.180

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.348

KCN5-20 ug/mL Potassium cyaniderespiration

-0.393

NaN30.2-2 mM Sodium aziderespiration

-0.326

Nigericin50 uM Nigericinrespiration

0.457

TRC10-150 ug/mL Triclosanrespiration

1.959

TRZ10-25 ug/mL Thioridazinerespiration

0.044

Valinomycin0.5-10 uM Valinomycinrespiration

-1.661

ZnSO42 mM ZnSO4respiration

1.426

menadione6-10 ug/mL Menadionerespiration

0.297

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.282

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.293

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.049

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.516

NRP_1Non-replicating persistence stage 1dosRassociated

-0.053

Amp0.2mg/mL AmpicillincellWall

-0.221

Cephalexin20-100 ug/mL CephalexincellWall

0.119

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.428

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.178

EMB10-20 ug/mL EthambutolcellWall

0.145

Eta12-40 ug/mL EthionamidecellWall

0.120

INH0.2-0.4 ug/mL IsoniazidcellWall

0.004

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.391

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.185

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.828

BZA0.12 mg/mL BenzamidearomaticAmides

-0.342

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.258

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.274

H2O24 mM hydrogen peroxideDNAdamaging

-0.478

Levo10 ug/mL LevofloxacinDNAdamaging

-0.730

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.212

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.379

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.555

UVUV-irradiationDNAdamaging

1.582

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.732

Antimycin12.5-50 ug/mL Antimycin A?

-0.697

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.804

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.001

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.179

PA8240.2-2 ug/mL PA-824?

0.609

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.368

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.079

Verapamil50 uM Verapamil?

-0.283

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.509

methoxatin10-20 ug/mL Methoxatin?